MedTrace Logo

Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients

NCT02035189 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-03-03

No results posted yet for this study

Summary

An observational study in evaluating the clinical impact of procalcitonin on the care of Stem cell transplant recipient and its performance as an adjunct in the diagnosis and prognostication of Infectious processes

Conditions

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Senu Apewokin, MD · University of Arkansas

  • Naveen Sanathkumar, MD · University of Arkansas

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02035189 on ClinicalTrials.gov